Risultati della ricerca - Isabel Poschke

Raffina i risultati
  1. 1
    Camouflage and sabotage: tumor escape from the immune system

    Camouflage and sabotage: tumor escape from the immune system di Isabel Poschke, Dimitrios Mougiakakos, Rolf Kiessling

    Pubblicazione 2011
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes

    Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes di Isabel Poschke, Yumeng Mao, Rolf Kiessling, Jana de Boniface

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Tumor‐induced changes in the phenotype of blood‐derived and tumor‐associated T cells of early stage breast cancer patients

    Tumor‐induced changes in the phenotype of blood‐derived and tumor‐associated T cells of early stage breast cancer patients di Isabel Poschke, Jana de Boniface, Yumeng Mao, Rolf Kiessling

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign

    Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign di Isabel Poschke, Dimitrios Mougiakakos, Johan Hansson, Giuseppe Masucci, Rolf Kiessling

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients

    Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients di Jana de Boniface, Yumeng Mao, Jan Schmidt‐Mende, Rolf Kiessling, Isabel Poschke

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer

    Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer di M. Miyan, J Schmidt-Mende, Rolf Kiessling, Isabel Poschke, Jana de Boniface

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines

    Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines di Isabel Poschke, Yumeng Mao, Lars Adamson, Flavio Salazar‐Onfray, Giuseppe Masucci, Rolf Kiessling

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer

    Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer di Natalie Hartmann, Nathalia A. Giese, Thomas Giese, Isabel Poschke, Rienk Offringa, Jens Werner, Eduard Ryschich

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

    Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis di Emilia Andersson, Isabel Poschke, Lisa Villabona, Joseph W. Carlson, Andreas Lundqvist, Rolf Kiessling, Barbara Seliger, Giuseppe Masucci

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    The CD16−CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset

    The CD16−CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset di Helena Harlin, Mikael Hanson, C. Christian Johansson, Daiju Sakurai, Isabel Poschke, Håkan Norell, Karl‐Johan Malmberg, Rolf Kiessling

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

    Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells di Mattias Carlsten, Håkan Norell, Yenan T. Bryceson, Isabel Poschke, Kjell Schedvins, Hans‐Gustaf Ljunggren, Rolf Kiessling, Karl‐Johan Malmberg

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma

    A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma di Isabel Poschke, Tanja Lövgren, Lars Adamson, Maria Nyström, Emilia Andersson, Johan Hansson, Roger Tell, Giuseppe Masucci, Rolf Kiessling

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

    Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production di Yago Pico de Coaña, Isabel Poschke, Giusy Gentilcore, Yumeng Mao, Maria Nyström, Johan Hansson, Giuseppe Masucci, Rolf Kiessling

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

    Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas di Anna Kruschinski, Andreas Moosmann, Isabel Poschke, Håkan Norell, Markus Chmielewski, Barbara Seliger, Rolf Kiessling, Thomas Blankenstein, Hinrich Abken, Jehad Charo

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

    Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms di Yumeng Mao, Isabel Poschke, Erik Wennerberg, Yago Pico de Coaña, Suzanne Egyházi Brage, Inkeri Schultz, Johan Hansson, Giuseppe Masucci, Andreas Lundqvist, Rolf Kiessling

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

    Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial di Håkan Norell, Isabel Poschke, Jehad Charo, Wei Z Wei, Courtney L. Erskine, Marie P. Piechocki, Keith L. Knutson, Jonas Bergh, Elisabet Lidbrink, Rolf Kiessling

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

    Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma di Yago Pico de Coaña, Maria Wolodarski, Isabel Poschke, Yuya Yoshimoto, Yuan Yang, Maria Nyström, Ulrika Edbäck, Søren Brage, Andreas Lundqvist, Giuseppe Masucci, Johan Hansson, Rolf Kiessling

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients

    Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients di Nora Liebers, Claudius Speer, Louise Benning, Peter‐Martin Bruch, Isabelle Kraemer, Julia Meißner, Paul Schnitzler, Hans‐Georg Kräusslich, Peter Dreger, Carsten Müller‐Tidow, Isabel Poschke, Sascha Dietrich

    Pubblicazione 2021
    Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  19. 19
    H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient

    H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient di Tamara Boschert, Kristina Kromer, Taga Lerner, Katharina A.M. Lindner, Gordon Haltenhof, Chin Leng Tan, Kristine Jähne, Isabel Poschke, Lukas Bunse, Philipp Eisele, Niklas Graßl, Iris Mildenberger, Katharina Sahm, Michael Platten, John M. Lindner, Edward W. Green

    Pubblicazione 2024
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

    Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination di Tanja Lövgren, Maria Wolodarski, Stina L. Wickström, Ulrika Edbäck, Mette Wallin, Eva Martell, Katrin Markland, Pontus Blomberg, Maria Nyström, Andreas Lundqvist, Hans Jacobsson, Gustav Ullenhag, Per Ljungman, Johan Hansson, Giuseppe Masucci, Roger Tell, Isabel Poschke, Lars Adamson, Jonas Mattsson, Rolf Kiessling

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: